Parkinson's patch gets FDA approval; NC plays host to nanotech summit;

> Neupro, a dopamine agonist patch for Parkinson's and restless-leg syndrome, got FDA approval, and its producer, Belgium's UCB, plans for a July launch in the U.S. Release

> North Carolina is playing host to the Nanotech Commercialization Conference this week, and with 40 nanobiotechnology companies in the state alone, the field could be a huge boon to the local economy. Story

> Frost Gamma Investments Trust bought about 24 million shares of Alliqua ($ALQA), a New York-based company developing a transdermal drug delivery platform using a proprietary hydrogel. Release

> Nordson ASYMTEK has joined forces with the University of Greenwich to develop state-of-the-art drug delivery systems using the company's DispenseMate D-583 benchtop dispensing technology. Report

And Finally... Inovio Pharmaceuticals ($INO) scored a $750,000 grant from the Department of Defense to test the safety of its surface electroporation drug delivery system, with the aim of developing synthetic vaccines to combat bioterrorism. News

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.